Sun Pharmaceutical Industries Limited (which includes its subsidiaries and/or associate companies) ("Company") has entered into an agreement to acquire 60% shareholding in Vivaldis Health And Foods Private Limited from its existing shareholders with remaining 40% shareholding to be acquired in future as per certain terms & conditions.
Vivaldis Health And Foods Private Limited ("Target"), a private limited company duly incorporated under the Companies Act, 2013, having corporate identification number ('CIN') U24297PN2014PTC150393 and having its registered office at Office No. 803, Clover Hills Plaza, SN-27(PT) Pl, Kondhwa, Pune - 411048, Maharashtra, India.
The Target is engaged in the business of trading, distributing, manufacturing and marketing of drugs, food supplements and over the counter products in the companion animal segment of animal healthcare industry.
The revenue for the financial year 2021-22 was INR 29.92 crores.
The cost of acquisition is INR 143.30 crores subject to customary closing adjustments for 60% (sixty percent) shareholding.
Shares of Sun Pharmaceutical Industries Limited was last trading in BSE at Rs. 972.80 as compared to the previous close of Rs. 977.30. The total number of shares traded during the day was 16196 in over 1440 trades.
The stock hit an intraday high of Rs. 978.50 and intraday low of 968.30. The net turnover during the day was Rs. 15774026.00.